At the 24-week mark, patients receiving the drug experienced average weight loss reduction ranging from 7.2% in the 1 mg group to 17.5% in the 12 mg group, compared to 1.6% in the placebo group
The real-world results we see in clinic come from combining a GLP-1 medication with structured nutrition advice, regular weighing-in, and a clinician available to manage side effects
Consider implementing structured refeeds, intermittent fasting windows, or cycling between higher and lower calorie days
If so, it might outcompete the other, effectively negating its presence
But this doesnt mean alcohol becomes safe for your liver while taking retatrutide
Ongoing Maintenance (Years 2-5) Research shows many people regain significant weight when discontinuing semaglutide